Epoprostenol is a prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. References: Ahmad KA, Banales J, Henderson CL, Ramos SE, Brandt KM, Powers GC. Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide. J Perinatol. 2018 Jul 25. doi: 10.1038/s41372-018-0179-7. [Epub ahead of print] PubMed PMID: 30046179.

纯度：≥98%

CAS：35121-78-9